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Many  degenerative  diseases  are  associated  with  increased 
oxidative stress. Creatine has the potential to act as an indirect 
and direct antioxidant; however, limited data exist to evaluate the 
antioxidant  capabilities  of  creatine  supplementation  within  in 
vivo human systems. This study aimed to investigate the effects 
of oral creatine supplementation on markers of oxidative stress 
and antioxidant defenses following exhaustive cycling exercise. 
Following preliminary testing and two additional familiarization 
sessions,  18  active  males  repeated  two  exhaustive  incremental 
cycling  trials  (T1  and  T2)  separated  by  exactly  7  days.  The 
subjects were assigned, in a double-blind manner, to receive either 
20 g of creatine (Cr) or a placebo (P) for the 5 days preceding T2. 
Breath-by-breath respiratory data and heart rate were continually 
recorded throughout the exercise protocol and blood samples were 
obtained at rest (preexercise), at the end of exercise (postexercise), 
and  the  day  following  exercise  (post24  h).  Serum  hypdroper-
oxide concentrations were elevated at postexercise by 17 ± 5% 
above preexercise values (p = 0.030). However, supplementation 
did  not  influence  lipid  peroxidation  (serum  hypdroperoxide 
concentrations), resistance of low density lipoprotein to oxida-
tive stress (t1/2max LDL oxidation) and plasma concentrations 
of non-enzymatic antioxidants (retinol, α-carotene, β-carotene, 
α-tocopherol, γ-tocopherol, lycopene and vitamin C). Heart rate 
and oxygen uptake responses to exercise were not affected by 
supplementation.  These  findings  suggest  that  short-term 
creatine supplementation does not enhance non-enzymatic anti-
oxidant defence or protect against lipid peroxidation induced by   
exhaustive cycling in healthy males.
Introduction
Creatine monohydrate has become a popular supplement, which 
is reputed to elevate intramuscular high-energy phosphates and 
thereby act as a temporal energy buffer to allow more work to be 
completed during high-intensity exercise.1 Creatine is a nitrogenous 
organic acid that is endogenously synthesized, predominantly in the 
liver, from glycine, arganine and methionine. Oral consumption of 
creatine monohydrate has been demonstrated to increase plasma 
creatine  concentrations2  and  enhance  total  creatine  concentra-
tions,3 which is mostly stored as creatine phosphate (CrP) within 
skeletal  muscles.  Consequently,  creatine  monohydrate  supple-
mentation  has  the  potential  to  improve  performance  during 
high-intensity exercise.
In addition to its ergogenic properties, creatine might augment 
cellular  energy  supply  and  attenuate  the  loss  of  cellular  Ca2+ 
homeostasis that has been associated with a range of disease popu-
lations.4 As the accumulation of intracellular Ca2+ has been widely 
implicated in the formation of reactive oxygen species (ROS) and 
oxidative damage,5 creatine supplementation has the potential to 
improve  Ca2+  homeostasis,  reduce  ROS  production  and  lessen 
oxidative  damage.  Lawler  et  al.6  were  the  first  to  report  direct 
antioxidant properties of creatine. In a series of highly controlled 
in-vitro  studies,  these  authors  demonstrated  that  creatine  was   
effective in scavenging a range of radicals, including superoxide 
anion. More recently, exogenous creatine has been demonstrated 
to scavenge ROS (including hydroxyl radical) as well as reactive 
nitrogen species in cultured human cells.7
There is a growing body of evidence to suggest that creatine 
supplementation might be beneficial in the prevention and/or treat-
ment of a number of neuromuscular and cardiovascular diseases, 
for  which  oxidative  stress  has  been  consistently  associated.  For 
example, creatine has been demonstrated to improve a variety of 
outcome measures in animal models of neurodegenerative diseases, 
such as Huntington’s disease,8 Parkinson’s disease,9 amyotrophic 
lateral sclerosis10,11 and other metabolic disorders.12 Also, pretreat-
ment with creatine has been shown to protect against ischemic 
injury in rodent models of stroke13,14 and creatine supplementation 
is an effective adjunct therapy in the protection of cardiac function 
and antioxidant defences in ovariectomized hamsters.15
Oxidative stress within the mitochondrial has been associated 
with aging, where oxidized nucleotides have been demonstrated to 
accumulate in the brain and muscle with age.16 Additionally, several 
studies have linked aging with reductions in the mRNA of genes 
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associated with mitochondrial structure and function in skeletal 
muscle and the accumulation of mitochondrial DNA mutations.17 
Consequently, mitochondrial dysfunction has been implicated in a 
downward spiral, whereby elevated ROS production causes further 
mitochondrial damage, mitochondrial dysfunction and increased 
oxidative stress.
Although a small number of reports, mainly anecdotal in nature, 
suggest that creatine supplementation has the potential to reduce 
oxidative  stress  in  diseased  populations,18,19  the  individualized 
nature of these degenerative diseases makes long-term random-
ized controlled clinical trials difficult to perform. Consequently, 
the efficacy of creatine in reducing oxidative stress in humans is 
unclear. It has been estimated that approximately 2–5% of the 
oxygen flux through the mitochondria is not completely reduced 
to  water  and  generates  ROS,20  such  as  superoxide  anions  and 
hydroxyl  radicals.  Under  normal  resting  conditions,  elaborate 
antioxidant  defences  are  able  to  prevent  oxidative  damage  to 
biological  molecules  including  lipids,  amino  acids  and  nucle-
otides.21 Exercise provoking large increases in whole-body oxygen 
uptake has the potential to generate ROS (particularly superoxide 
anions) through the reperfusion of hypoxic tissues in addition to 
ROS produced through the elevated mitochondrial oxygen flux. 
Therefore,  strenuous  concentric  muscle  activity  could  increase 
ROS  production,  overwhelm  normal  antioxidant  defences,  and 
induce oxidative stress; indeed, exhaustive cycling has been demon-
strated to elevate measurements of ROS and lipid peroxidation in 
apparently healthy humans.22
Creatine has potential antioxidant properties (direct and indi-
rect) and has been shown to reduce free radical production and 
oxidative  stress  in  various  animal  models  of  disease;  however, 
limited in-vivo data exists to evaluate the effects of oral creatine 
monohydrate  supplementation  on  oxidative  stress  in  humans. 
Therefore, the purpose of the current study was to investigate the 
proposed antioxidant effects of short-term creatine monohydrate 
supplementation  on  antioxidant  defences  and  oxidative  stress 
following exhaustive cycling exercise.
Results
The  environmental  conditions  were  similar  during  all  trials, 
ambient temperature being 21.8 ± 0.1 and 21.9 ± 0.2°C, baro-
metric  pressure  766  ±  1  and  766  ±  2  mmHg,  and  humidity   
45.2 ± 1.8 and 44.3 ± 1.9%, for T1 and T2 respectively. The 
calculated  daily  diet  comprised  of  8.9  ±  0.3  MJ·d-1,  of  which   
45  ±  2,  32  ±  2,  17  ±  1  and  6  ±  3%  of  energy  intake  was 
obtained from carbohydrates, fat, protein and alcohol, respectively.   
No differences were identified between groups or trials for calcu-
lated antioxidant vitamin intakes (Vitamin A: 528 ± 2.6 μg·d-1; 
Vitamin C: 47 ± 6 mg·d-1; Vitamin E: 6.1 ± 0.5 mg·d-1).
Peak exercising heart rate and whole-body oxygen uptake were 
similar during all trials (Table 1), being 194 ± 1 beats min-1 and 
3.97 ± 0.07 L·min-1, respectively. Net whole-body oxygen uptake 
during exercise (55.5 ± 2.1 L) was similar between supplementation 
groups and did not change following supplementation (Table 1).
Supplementation did not influence changes in plasma volume 
(trial x timing x group effect, p = 0.359) and these values were 
similar between trials (trial effect, p = 0.146), being -9.7 ± 0.8% 
from preexercise values at postexercise and returning to preexercise 
values at post24 h (1.6 ± 1.3%).
Blood  lactate  concentrations  were  similarly  elevated  from 
preexercise  (1.12  ±  0.06  mmol·L-1)  at  postexhaustion  (8.31  ± 
0.21 mmol·L-1) and postexercise (4.98 ± 0.20 mmol·L-1) during 
all  trials  (p  <  0.001)  (Table  2).  Blood  glucose  concentrations 
were  not  significantly  different  for  preexercise,  postexhaustion,   
postexercise and post24 h, being 4.17 ± 0.09, 4.35 ± 0.07 and 4.32 
± 0.07 mmol·L-1, respectively, for all trials (Table 2).
Exercise did not change t1/2max LDL oxidation (time of sample 
effect,  p  =  0.502)  and  supplementation  did  not  influence  the 
pattern of these values (trial x timing of sample x group effect,   
p  =  0.331),  with  preexercise,  postexercise  and  post24  h   
values being 97.5 ± 3.9, 96.6 ± 3.8, 96.1 ± 4.3 min, respectively 
(Table 2).
Serum hypdroperoxide concentrations were elevated at postex-
ercise by 17 ± 5% above preexercise values (time of sample effect, 
p = 0.030) in all trials (Fig. 1). The three-way interaction effect 
was  not  significant  (trial  x  timing  of  sample  x  group  effect,  p 
=  0.205)  and  no  difference  existed  between  trials  (trial  effect,   
p = 0.959).
Supplementation  did  not  influence  the  pattern  of  response 
in any of the measured antioxidant vitamins (trial x timing of   
sample  x  group  effect,  p  ≥  0.176).  Exercise  elevated  plasma   
concentrations of retinol by 7.2 ± 3.0% (time of sample effect, 
p  =  0.015).  Plasma  concentrations  of  α-carotene,  β-carotene, 
α-tocopherol, γ-tocopherol, lycopene and vitamin C were similar 
throughout the duration of each trial and were not significantly 
different  between  trials  (time  of  sample  effect,  p  ≥  0.078)   
(Table 3).
Discussion
The main findings of this study were that creatine supplementa-
tion (20 g·d-1 of creatine administered for 5 d) was not effective in 
attenuating oxidative stress, did not influence the   concentrations 
of  non-enzymatic  antioxidant  vitamins,  and  did  not  alter  the 
susceptibility  of  LDL  particles  to  oxidative  stress  in  previously 
familiarized healthy individuals.
Creatine supplementation and oxidative stress
Table 1    Heart rate and oxygen uptake responses to 
exhaustive exercise before (Trial 1) and after 
(Trial 2) supplementation with creatine and 
placebo
    Trial 1  Trial 2  Effect: P 
        interaction, 
        trial
Peak Heart Rate  Cr  195 ± 3  194 ± 3  0.719 
(beats·min-1)  P  193 ± 2  192 ± 1  0.523
Peak Oxygen Uptake   Cr  3.92 ± 0.15  3.83 ± 0.13  0.739 
(L·min-1)  P  4.01 ± 0.14  4.02 ± 0.18  0.399
Net Oxygen Uptake  Cr  52.22 ± 3.28  51.46 ± 3.18  0.971 
(L)  P  58.86 ± 4.81  59.66 ± 4.77  0.145
Values are last minute values; presented as mean ± SEM (N = 9). Definitions: Cr, Creatine group; 
P, Placebo group. Effects present p-values for supplementation group x trial interaction effect and trial 
effect.Creatine supplementation and oxidative stress
  electron  spin  resonance  (ESR)  signal  in  the  plasma  of  healthy 
young  subjects.22  These  authors  suggested  that  the  enhanced 
postexercise ESR signal reflected an increase in the concentration 
of alkoxyl radicals formed as a consequence of primary ROS (such 
as superoxide anion and hydroxyl radicals) attack on membrane 
phospholipids.
The  amount  of  external  work  undertaken  during  the  indi-
vidualised  exhaustive  protocol  was  matched  during  T1  and 
T2;  furthermore,  heart  rate,  oxygen  uptake  and  blood  lactate 
concentrations reached similar peak values at the end of exercise 
during all trials suggesting that the protocol challenged all subjects 
to an equal extent. Net whole-body oxygen uptake was similar 
between groups and trials (Table 2). Assuming that the rate of 
mitochondrial ROS production remained approximately constant 
The  cycling  protocol  increased  lipid  peroxidation  above   
preexercise  values,  as  measured  by  increased  postexercise  serum 
hypdroperoxide  concentrations.  The  relative  change  in  lipid 
peroxidation (17 ± 5%) was less than we previously reported after 
intermittent running, where increases of 24 ± 5% were measured.23 
Exhaustive cycling does not involve significant amounts of eccen-
tric muscle activity and structural muscle damage; therefore, unlike 
intermittent  running,  cycling  does  not  lead  to  inflammation-
mediated  free  radical  production  that  follows  structural  muscle 
damage.24  Consequently,  during  the  current  study,  it  is  likely 
that  increased  mitochondrial  oxygen  flux  led  to  elevated  ROS 
production that overwhelmed the antioxidant defences and caused 
oxidative stress. In support of this premise, incremental cycling 
has previously been demonstrated to increase the intensity of the 
Table 2    Conjugated diene lag times and blood concentrations of lactate and glucose before (trial 1) and after 
(trial 2) supplementation with creatine (Cr) and placebo (P)
    Trial 1  Trial 1  Trial 1  Trial 1  Trial 2  Trial 2  Trial 2  Trial 2  Effect: P 
    Preexercise  Postexhaustion  Postexercise  Post24 h  Preexercise  Postexhaustion  Postexercise  Post24 h   interaction, 
             timing
Lactate  Cr  1.02 ± 0.08  8.21 ± 0.52  5.00 ± 0.38  0.89 ± 0.08  1.04 ± 0.10  8.51 ± 0.49  5.23 ± 0.48  1.09 ± 0.20  0.585 
(mmol·L-1)  P  1.08 ± 0.14  8.25 ± 0.42  4.90 ± 0.41  1.29 ± 0.28  1.33 ± 0.16  8.26 ± 0.34  4.80 ± 0.35  1.34 ± 0.20  <0.001
Glucose  Cr  4.14 ± 0.17  4.18 ± 0.14  4.44 ± 0.25  4.09 ± 0.08  3.85 ± 0.19  4.25 ± 0.12  4.44 ± 0.26  4.29 ± 0.10  0.132 
(mmol·L-1)  P  4.20 ± 0.05  4.58 ± 0.11  4.74 ± 0.18  4.27 ± 0.11  4.48 ± 0.21  4.40 ± 0.16  4.48 ± 0.15  4.63 ± 0.21  0.059
t1/2max LDL  Cr  89.0 ± 7.1  -  87.3 ± 6.3  88.1 ± 6.3  93.0 ± 8.4  -  91.1 ± 7.7  88.0 ± 6.1  0.502 
(min)  P  102.5 ± 8.7  -  105.0 ± 7.9  100.9 ± 7.5  104.4 ± 7.3  -  103.1 ± 7.6  107.4 ± 12.4  0.393
Values are presented as mean ± SEM (N = 9). Definitions: Cr, Creatine group; P, placebo group. Effects present p-values for supplementation group x trial x timing of sample interaction effect and timing 
effect.
Figure  1.  Exercise-induced  lipid  peroxidation  as  measured  by  serum  hydroperoxide  concentrations.  Exhaustive  cycling  caused  increases  in  lipid   
peroxidation (time of sample effect, p = 0.030), with serum hydroperoxide concentrations being elevated after exercise (ost-exercise) when compared 
with values before (Pre-exercise) and 24 hours after exercise (Post-24 h). The pattern of response was similar following supplementation with creatine 
(Cr) and placebo (P) (trial x timing of sample x group effect, p = 0.205). Values represent mean ± SEM (N = 9).
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α-carotene, β-carotene, α-tocopherol, γ-tocopherol, and lycopene, 
and vitamin C). In addition, the two main exercise trials were 
completed within 7 d; therefore, it is likely that the enzymatic 
antioxidant defences remained similar for each individual during 
both main exercise trials. As the enzymatic and non-enzymatic 
vitamin  antioxidant  defence  were  comparable  between  exercise 
trials, this repeated measure design was suitable to assess the influ-
ence  of  short-term  oral  creatine  supplementation  as  an  in-vivo 
antioxidant.
Supplementation did not influence the pattern of response in 
serum hydroperoxide concentrations (trial x timing of sample x 
group effect, p = 0.205). Although there was a tendency for mean 
serum  hydroperoxide  concentrations  to  be  reduced  following 
supplementation  with  creatine  (Fig.  1),  creatine  supplementa-
tion did not significantly influence lipid peroxidation following 
exhaustive  cycling.  Therefore,  the  current  finding  does  not 
confirm previous in-vitro data showing that creatine acts a direct 
antioxidant.6,7 Lawler et al.6 were the first to report that creatine 
effectively quenches superoxide anions and other aqueous radical 
species in highly controlled cell-free environments. Later, intrac-
ellular creatine was also shown to act as a direct antioxidant by 
scavenging ROS (particularly hydroxyl radicals) in cultured cells.7 
Mitochondrial ROS production (including superoxide anions and 
hydroxyl radicals) is likely to be the primary source of free radicals 
during cycling; consequently, it is unclear why the current creatine 
supplementation regime, which has been previously demonstrated 
to increase plasma and intramuscular creatine, was ineffective in 
attenuating lipid peroxidation in the current study.
Differences between in-vivo and in-vitro systems might partially 
explain the lack of statistical evidence to support an antioxidant 
effect in the current study. Although the current supplementation 
regime has been shown to “load” muscle cells to threshold levels,3 
considerable heterogeneity exists in intramuscular creatine uptake 
following oral supplementation. It is, therefore, possible that the 
for all individuals, the exercise protocol was effective in producing 
similar amounts of ROS during T1 and T2. Consequently, this 
repeated measures design was successful in challenging the anti-
oxidant defences of all subjects to a comparable extent during the 
main exercise trials.
The finding that creatine supplementation did not influence 
oxygen  uptake  during  exhaustive  exercise  is  in  agreement  with 
previous literature.25,26 Further evidence to suggest that cardio-
pulmonary function during exhaustive exercise was unaffected by 
creatine supplementation was provided by the similarity in heart 
rate  and  net  oxygen  uptake  responses  before  and  after  supple-
mentation. In support of this conclusion, most previous studies 
that evaluate similar outcomes have failed to identify any effect 
of creatine supplementation on aerobic capacity in healthy27-31 
and  diseased  populations.32-34  Nevertheless,  some  studies  have 
demonstrated that creatine supplementation can influence other 
parameters  that  have  the  potential  to  contribute  to  improved 
endurance  performance.  For  example,  creatine-induced  hyper-
hydration  has  been  shown  to  attenuate  heart  rate  responses  to 
prolonged  exercise  in  the  heat26  and  creatine  supplementation 
has  been  demonstrated  to  increase  lactate  threshold,27  improve 
submaximal  effeciency,31  and  enhance  peak  work  capacity  at 
fatigue during discontinuous exercise in elderly participants.35
It has been repeatedly demonstrated that the current creatine 
monohydrate  supplementation  regime  is  effective  in  increasing 
circulatory creatine concentrations2,3 and pharmacokinetic   analysis 
of plasma creatine concentrations following a 5-g oral bolus of 
creatine monohydrate showed that plasma creatine decayed with a 
half-life of approximately 2 h.36 Therefore, it is probable that the 
current supplementation protocol elevated plasma and intramus-
cular creatine concentrations.
Calculated  intakes  of  the  main  dietary  antioxidant  vitamins 
were similar during all trials and supplementation had no effect 
on  plasma  concentrations  of  the  antioxidant  vitamins  (retinol, 
Table 3    Plasma antioxidant vitamin concentrations before (trial 1) and after (trial 2) supplementation with  
creatine (Cr) and placebo (P)
    Trial 1  Trial 1  Trial 1  Trial 2  Trial 2  Trial 2  Effect P 
    Preexercise  Postexercise  Post24 h  Preexercise  Postexercise  Post24 h  interaction, timing
retinol  Cr  2.1 ± 0.2  2.2 ± 0.2  2.3 ± 0.2  2.1 ± 0.2  2.3 ± 0.2  2.3 ± 0.2  0.482 
(μmol·L-1)  P  2.3 ± 0.3  2.3 ± 0.3  2.4 ± 0.2  2.2 ± 0.3  2.5 ± 0.3  2.2 ± 0.2  0.015
α-carotene  Cr  0.20 ± 0.05  0.22 ± 0.04  0.21 ± 0.04  0.18 ± 0.04  0.16 ± 0.04  0.17 ± 0.03  0.401 
(μmol·L-1)  P  0.15 ± 0.02  0.17 ± 0.01  0.16 ± 0.02  0.15 ± 0.02  0.16 ± 0.02  0.15 ± 0.02  0.870
β-carotene  Cr  0.61 ± 0.15  0.70 ± 0.13  0.70 ± 0.18  0.55 ± 0.12  0.49 ± 0.12  0.47 ± 0.10  0.176 
(μmol·L-1)  P  0.42 ± 0.07  0.46 ± 0.07  0.47 ± 0.12  0.43 ± 0.07  0.53 ± 0.14  0.49 ± 0.11  0.563
α-tocopherol  Cr  28.3 ± 1.8  29.1 ± 2.2  29.9 ± 2.5  28.7 ± 1.6  28.2 ± 1.8  28.2 ± 1.6  0.876 
(μmol·L-1)  P  29.5 ± 2.7  31.0 ± 2.6  31.2 ± 2.6  29.5 ± 2.6  31.0 ± 2.6  31.2 ± 2.6  0.078
γ-tocopherol  Cr  1.4 ± 0.1  1.3 ± 0.1  1.4 ± 0.2  1.2 ± 0.1  1.1 ± 0.1  1.2 ± 0.1  0.419 
(μmol·L-1)  P  1.5 ± 0.2  1.5 ± 0.1  1.5 ± 0.1  1.5 ± 0.2  1.7 ± 0.2  1.7 ± 0.2  0.481
lycopene  Cr  1.4 ± 0.3  2.0 ± 0.4  1.9 ± 0.5  1.5 ± 0.5  1.3 ± 0.3  1.2 ± 0.3  0.514 
(μmol·L-1)  P  1.3 ± 0.5  1.5 ± 0.3  1.2 ± 0.1  1.0 ± 0.1  1.8 ± 0.4  1.0 ± 0.2  0.087
vitamin C  Cr  45.0 ± 3.9  48.1 ± 4.5  42.7 ± 6.0  49.7 ± 4.9  44.5 ± 4.1  47.1 ± 5.6  0.631 
(μmol·L-1)  P  48.1 ± 2.9  43.0 ± 4.3  47.4 ± 4.6  41.7 ± 3.5  42.3 ± 5.1  44.1 ± 5.6  0.230
Values are presented as mean ± SEM (N = 9). Definitions: Cr, Creatine group; P, Placebo group. Effects present p-values for supplementation group x trial x timing of sample interaction effect and timing 
effect.Creatine supplementation and oxidative stress
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potential to reduce ROS production through better maintenance 
of  cellular  energetics  as  well  as  quench  ROS  and  other  radical 
species. Indeed, oral creatine supplementation has been demon-
strated  to  reduce  oxidative  stress  and  prevent  paracrystalline 
inclusions in a patient with mitochondrial dysfunction.19 A small 
number  of  randomised  clinical  trials  have  evaluated  the  effects 
of short- to moderate-term creatine supplementation in patients 
with diseases that have been traditionally associated with oxida-
tive stress, such as Huntington’s disease,39 Parkinson’s disease,40-42 
amyotrophic lateral sclerosis,43-45 rheumatoid arthritis,46 chronic 
obstructive  pulmonary  disease47  and  congestive  heart  failure.38 
Although equivocal, these studies have generally reported small 
positive  effects  in  a  range  of  outcome  measures.  Nevertheless, 
no data from randomised clinical trials are currently available to 
evaluate the influence of creatine supplementation on oxidative 
stress in patient populations.
In summary, this is the first study to evaluate the effects of 
creatine supplementation on acute exercise-derived oxidative stress 
in healthy young males. Short-term creatine supplementation was 
ineffective in attenuating oxidative stress (as measured by serum 
hydroperoxide concentrations) induced by exhaustive cycling; in 
addition, supplementation did not influence LDL susceptibility to 
oxidative stress exercise or change plasma concentrations of anti-
oxidant vitamins. Nevertheless, it remains possible that creatine 
supplementation  could  benefit  patient  populations  that  have 
increased susceptibility to oxidative stress due to impaired cellular 
energy metabolism and decreased antioxidant defences.
Methods
Subjects. Eighteen healthy male volunteers (age: 21.5 ± 0.4 
years; stature: 1.77 ± 0.01 m; body mass: 81.1 ± 2.0 kg; body 
composition: 16.8 ± 0.7%BF) were informed about the potential 
risks of the study and gave written informed consent for their 
participation in the study, which was approved by a local research 
ethics committee. No subject had prior history of cardiovascular 
or respiratory disease and all subjects were non-smokers. Potential 
subjects attended an interview prior to undertaking the study and 
were subsequently excluded if they engaged in a structured weight 
training programme, or had taken creatine or other nutritional 
supplements in the 8 weeks prior to the study.
Experimental design. Prior to the main exercise trials, all subjects 
completed three incremental exercise tests (separated by exactly 7 
d)  in  order  to  ensure  that  the  subjects  were  fully  familiarized 
and able to repeat the exhaustive exercise protocol. Subjects then 
performed two main exercise trials, which consisted of incremental 
cycling that was continued until the individualized predetermined 
point  of  exhaustion  (determined  during  the  preliminary  trials), 
and separated by exactly 7 d. Two days after completing the first 
main exercise trial (T1) the subjects were assigned, in a randomised 
double-blind fashion, to either a creatine (Cr) group or a placebo (P) 
group and instructed to take supplements for 5 d, which included 4 
d prior to and the day of trial two (T2). The subject characteristics 
of each group are presented in Table 4. The Cr group ingested 22.8 
g·d-1 Cr·H2O (equivalent to 5 g Cr x 4 daily) for 5 d. Each supple-
ment dose consisted of 5.7 g Cr·H2O and 5 g of glucose polymer 
change in intracellular creatine concentrations from T1 to T2 in   
Cr  was  insufficient  to  cause  significant  differences  in  lipid   
peroxidation. This finding suggests that increasing intramuscular 
creatine in healthy young males does not afford additional protec-
tion against oxidative damage derived from strenuous concentric 
muscle activity.
Supplementation  did  not  influence  t1/2max  LDL  oxidation 
(Table 3). As t1/2max LDL oxidation measures the resistance of 
LDL particles to oxidation, these data suggest that creatine did not 
alter the antioxidant defences of LDL particles in healthy young 
males. Unlike the current data, some recent studies have previ-
ously demonstrated that prolonged exercise involving considerable 
eccentric  muscular  activity  causes  significant  increases  in  LDL 
resistance to peroxidation in healthy males.23,37 These equivocal 
results  probably  reflect  increased  mobilisation  of  antioxidant 
defences following prolonged exercise that leads to muscle damage 
and acute inflammation.
Similar doses of creatine have been repeatedly demonstrated to 
enhance short-term exercise performance in healthy individuals, 
which has generally been ascribed to enhanced temporal energy 
buffering through increased intramuscular CrP.1 Supplementation 
did not influence peak values for heart rate, oxygen uptake, and 
blood  glucose  and  lactate  concentrations  (Table  3);  therefore 
the metabolic responses to matched exhaustive exercise were not 
changed  by  creatine  supplementation.  Nevertheless,  Andrews 
et al.38 showed that creatine supplementation attenuated blood 
concentrations  of  lactate  and  ammonia  responses  to  exhaustive 
handgrip  dynamometry  exercise  in  patients  with  chronic  heart 
failure.  Consequently,  creatine  supplementation  might  be  more 
effective in maintaining cellular energy supply in patient popula-
tions; thereby, reducing the accumulation of intracellular Ca2+, 
limiting  the  formation  of  reactive  oxygen  species  (ROS)  and 
attenuate oxidative damage.5
Although the current data does not support in-vivo antioxidant 
benefits, mediated by direct or indirect mechanisms, from short-
term creatine supplementation in healthy young males, it remains 
possible  that  individuals  with  diseases  that  are  associated  with 
reduced  antioxidant  defences  and  elevated  radical  production, 
probably through an impairment in cellular energy metabolism, 
might benefit from creatine supplementation. Creatine is unique, 
within  the  currently  available  antioxidants,  in  that  it  has  the   
Table 4    Subject characteristics for creatine  
supplementation group (Cr) and placebo group 
(P)
Characteristic  Cr (N = 9)  P (N = 9)  p-value
Age (dec. years)  21.7 ± 0.8  21.2 ± 0.2  0.638
Mass (kg)  77.9 ± 2.8  84.3 ± 2.5  0.103
Height (m)  1.77 ± 0.02  1.77 ± 0.01  0.956
Body composition (%BF)  18.2 ± 0.8  15.4 ± 1.0  0.061
Maximal oxygen uptake  50.8 ± 1.9  48.0 ± 1.7  0.290 
(ml·kg-1·min-1)
Values are mean ± SEM. p-value calculated using independent sample t-test.Creatine supplementation and oxidative stress
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exhaustion  (postexhaustion)  for  the  analysis  of  blood  lactate 
and glucose concentrations. Ambient temperature and humidity 
were recorded at the beginning and end of exercise (ETHG-912; 
Oregan Scientific, USA).
Blood sampling and analysis. Venous blood was collected in a 
5 mL container (Becton-Dickinson Ltd., UK) containing the anti-
coagulant ethylenediamine tetraacetic acid (EDTA). Several small 
aliquots were removed for the triplicate determination of blood 
lactate  concentration,  glucose  concentration  (YSI  2300,  Yellow 
Springs Instruments, US), hemoglobin concentration (Hemocue 
Ltd.,  UK),  hematocrit  (Micro  hematocrit  MK  IV,  Hawksley, 
UK) and changes in plasma volume were estimated as previously 
described.49 The remaining blood was centrifuged at 3,000 g for 
15 min to obtain plasma. An aliquot of plasma (100 μL) was 
added to 900 μL of freshly prepared 10% metaphosphoric acid, 
mixed and frozen at -70°C for subsequent vitamin C analysis. The 
remaining plasma was frozen in aliquots and stored at -70°C prior 
to subsequent analysis. Two additional 7 mL blood samples were 
collected in serum separation tubes (Becton-Dickinson Ltd., UK), 
left to stand for 15 min then centrifuged at 3,000 g for 15 min to 
obtain serum. The serum was transferred to appropriate containers 
and subsequently stored at -70°C prior to analysis.
Serum hydroperoxide concentrations were measured as described 
in McEneny et al.50 Low density lipoprotein was isolated from 
plasma and oxidised according to the method of McDowell et al.51 
Subsequently, the production of conjugated dienes was followed 
in  triplicate  at  234  nm  (SpectraMax  190;  Molecular  Devices 
Corp., US) using the computer software SoftMax Pro Version 3.0 
(Molecular Devices Corp., US); the change in absorbance (from 
baseline to the maximum absorbance following the propagation 
dissolved in 500 ml of warm water. This regimen was adopted in 
light of the work by Harris et al.2 who found that this protocol 
resulted in significant increases in total creatine content of resting   
quadriceps femoris muscle; in addition, the majority of studies that 
have shown a direct or indirect increase in total creatine concen-
tration  have  used  similar  supplementation  regimes.  Dissolving 
creatine  in  warm  water  prevented  any  detectable  formation  of 
creatinine, with no parts of the supplement remaining undissolved. 
The placebo group consumed 40 g·d-1 of glucose polymer. Both 
supplements had similar taste, texture and appearance, and were 
administered  in  generic  packaging.  Subjects  were  instructed  to 
maintain their normal diet and activity patterns throughout the 
study. Food was weighed and recorded by the subjects for 2 d prior 
to each exercise trial and for 1 d afterwards. These food records 
were subsequently analyzed using commercial software (CompEat 
version v5.8.0; Nutrition Systems, UK). In addition, the subjects 
were instructed to abstain from strenuous exercise for 3 d before 
and 1 d following each trial. At the completion of the study all 
subjects gave their verbal assurance that they had complied with all 
instructions. The experimental design is illustrated in Figure 2.
Preliminary  procedures.  Subjects  were  habituated  with  the 
exercise protocol on three separate occasions prior to the main 
exercise trials. After a 5-min warm-up at 60 W and a 3-min rest 
period the subjects completed an incremental exercise test on an 
electromagnetically braked cycle ergometer (Lode Excalibur Sport; 
Lode,  Holland). The  work  rate  began  at  60  W  and  thereafter 
increased in 10-W increments every 1 min until volitional exhaus-
tion, which was defined as an inability to maintain a cadence of 60 
rev min-1 despite verbal encouragement. The time to exhaustion 
during the preliminary tests were used to determine the exercise 
time for the main exercise trials; therefore, the individualised exer-
cise protocol was recorded and repeated during both main exercise 
trials. Heart rate (S810; Polar Electro Oy, Finland) and breath-by-
breath respiratory parameters (Oxycon Pro; Jaeger, Germany) were 
simultaneously  recorded  throughout  exercise.  Breath-by-breath 
oxygen uptake during exercise was used to calculate net oxygen 
uptake.
During the initial preliminary session, mass (model 712; Seca, 
Germany) and stature (Portable Stadiometer; Holtain, UK) were 
measured; additionally, percentage body fat (BF) was determined 
using bioelectrical impedance analyses (Quadscan; Bodystat, Isle of 
Man), as previously described.48
Main trial procedures. On the day of each main exercise trial 
the subjects reported to the laboratory at approximately the same 
time of day (±1 h) and following an overnight fast. After 5-min of 
cycling at 60 W and a 3-min rest period the subjects completed 
the  individualized  incremental  cycling  protocol.  Subjects  were 
instructed  to  pedal  at  a  constant  cadence  between  65  and  75 
rev  min-1.  Heart  rate  (S810;  Polar  Electro  Oy,  Finland),  and 
breath-by-breath  respiratory  parameters  (Oxycon  Pro;  Jaeger, 
Germany)  were  simultaneously  recorded  throughout  exercise. 
Blood samples were taken by venepuncture (Vacutainer system; 
Becton-Dickinson Ltd., UK) in a seated position from an antecu-
bital vein before exercise (preexercise), 20 min after the completion 
of  exercise  (postexercise),  and  24  h  after  the  trial  (Post24  h). 
Additional capillary blood samples were taken immediately after 
Figure 2. Schematic diagram representing the experimental design that 
was used to evaluate the role of creatine supplementation on exercise-
induced  cardiovascular  function  and  oxidative  stress.  After  repeated 
familiarization, the subjects performed two main exercise trials that con-
sisted of exhaustive incremental cycling. Two days after completing the 
first main exercise trial (T1) the subjects were assigned, in a randomised 
double-blind fashion, to either a creatine (Cr) group or a placebo (P) 
group and instructed to take supplements for 5 d, which included 4 d 
prior to and the day of trial two (T2).Creatine supplementation and oxidative stress
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phase)  was  used  to  quantify  conjugated  diene  concentration,   
and  the  time  taken  to  reach  half  of  the  maximum  oxidation   
(t1/2max LDL oxidation), which directly correlates with conjugated 
diene lag time, was taken as a measure of the resistance of the 
particle to oxidation. The duration of the conjugated diene lag 
time has been shown to correlate with endogenous antioxidants 
in  LDL.52  Vitamin  C  concentrations  were  determined  using 
a  fluorimetric  assay  using  a  centrifugal  analyser  with  fluores-
cence  attachment  according  to  the  method  of Vuilleumier  and 
Keck.53 Plasma concentrations of retinol, α-carotene, β-carotene, 
α-tocopherol,  γ-tocopherol  and  lycopene  were  measured  by   
high-performance  lipid  chromatography  with  electrochemical 
detection according to the methods of Craft.54 The intra-assay 
coefficient of variance (%CV) for these assays ranged from 1.4 for 
α-tocopherol to 12.0 for lycopene.
Statistical  analysis.  Statistical  analysis  was  carried  out  using 
SPSS software (version 13.0; SPSS Inc., IL, US). Group data were 
expressed as mean ± SEM and statistical significance was set at 
the p < 0.05 level. All data were assessed for normality (Shapiro-
Wilk’s test) and data that were not normally distributed (plasma 
retinol, α-tocopherol and lycopene concentrations) were log trans-
formed prior to analyses. Subject characteristics were compared 
under supplementation groups using independent samples t-tests   
(Table 1). Environmental conditions were compared using paired 
samples  t-tests.  Body  composition,  heart  rate  and  whole-body 
oxygen  uptake  measurements  were  assessed  using  mixed-model 
repeated measures ANOVA (within-subject factors: trials; between-
subject  factor:  supplementation  groups).  The  remaining  data, 
which  contained  multiple  time  points  during  each  trial,  were 
analysed using mixed-model repeated measures ANOVA (within 
subject  factors:  trial  x  time  of  sample;  between  subject  factor: 
group).  Mauchly’s  test  was  consulted  and  Greenhouse-Geisser 
correction was applied if the assumption of sphericity was violated. 
If a significant p value was identified for the three-way interac-
tion (group x trial x time of sample), the subject groups reacted   
differently  and  supplementation  was  deemed  to  have  had  a   
significant effect. Where a significant p value was identified for the 
main effect of time (time of sample), multiple pairwise compari-
sons were made using Bonferonni confidence interval adjustment.
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